MARKET

CNST

CNST

Constellation Pharmaceuticals
NASDAQ

Real-time Quotes | Nasdaq Last Sale

37.40
+0.17
+0.46%
Opening 10:18 01/28 EST
OPEN
37.40
PREV CLOSE
37.23
HIGH
37.54
LOW
37.20
VOLUME
15.49K
TURNOVER
--
52 WEEK HIGH
59.49
52 WEEK LOW
6.01
MARKET CAP
1.01B
P/E (TTM)
-11.8824
1D
5D
1M
3M
1Y
5Y

Buy or sell shares of CNST and other stocks commission-free!

Open a Webull account and fund it to get a free stock

Analyst Rating

Based on 7 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

EPS

CNST News

  • Top Biotech Stocks for Q1 2020
  • Investopedia.01/09 19:50
  • Constellation Pharmaceuticals to Present at J.P. Morgan Healthcare Conference
  • GlobeNewswire.01/06 17:34
  • Constellation Pharma Filing Shows Registration For ~7.64M Common Share Offering Via Selling Shareholders
  • Benzinga.12/17/2019 21:34
  • Hedge Funds Have Never Been More Bullish On Constellation Pharmaceuticals, Inc. (CNST)
  • Insider Monkey.12/16/2019 11:00

More

Industry

Biotechnology & Medical Research
+1.35%
Pharmaceuticals & Medical Research
+0.70%

Hot Stocks

Name
Price
%Change

About CNST

Constellation Pharmaceuticals Inc. is a clinical-stage biopharmaceutical company. The Company is primarily if focused on discovering and developing therapeutics that address serious unmet medical needs in patients with cancers associated with abnormal gene expression and drug resistance. The Company has two clinical-stage oncology development programs: the first program is evaluating a compound, CPI-1205, and the other program is evaluating a compound, CPI-0610.
More

Webull offers Constellation Pharmaceuticals Inc (CNST) stock price, real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, stock news, and many more online research tools to help you make informed decisions.